1/28/2021Citrine Med and Diurnal Announce Strategic Partnership for Pediatric ...

1/28/2021Harbour BioMed's Batoclimab Receives Chinese Breakthrough Therapy Desi...

1/28/2021NDRC Issues the Catalogue of Industries for Encouraging Foreign Invest...

1/28/2021A Share-Listed Chinese MedPharm Cos Report Financial Performance in 20...

1/28/2021State Council Issues New Policy Document for Centralized Drug VBP

1/28/2021Bio-Techne Invests in China-based Cell and Gene Therapy Media Company

1/28/2021Bio-Thera Files Biologics License Application Avastin Biosimilar with ...

1/27/2021NH Reports on Chinese OTC Eye Care Market in MAT 09/2020

1/27/2021NH Reports Latest Data on Chinese Smoking Control Market

1/27/2021NH Reports on Chinese OTC Sleep Aids Market in MAT 09/2020

1/27/2021Novartis Aims to Double China Business by 2024

1/27/2021Biogen Employee Traveling to China with COVID-19 Last March Handed A S...

1/27/2021CDE Solicits Comments on Two Technical Documents for Pharmaceutical St...

1/26/2021EUSA and BeiGene Announce Acceptance of a Biologics License Applicati...

1/26/2021Antengene Granted Chinese IND Approval for ATG-010 (Selinexor) in Co...

1/26/2021AstraZeneca Granted Additional Indiciation for Asthma Drug Symbicort T...

1/26/2021Photocure Partners with Asieris MediTech to Commercialize Hexvix in Ma...

1/26/2021CDE Issues the Technical Guidelines for Bioequivalence Study of 11 Dru...

1/26/2021CDE Issues the Technical Guidelines for Drug Interaction Research

1/25/2021NMPA Issues the List of Reference Formulations for GQCE Studies (36th ...

1/25/2021CDE Issues the ICH Guidelines E9(R1), S5(R3) and S11

1/25/2021NMPA Revises Packages Inserts of Gefitinib Tablets

1/25/2021NMPA Publicizes the List of Reference Formulations for GQCE Studies (3...

1/25/2021China's Meituan to Shut Down Healthcare Mutual Aid Program

1/22/2021Everest Medicines Granted Clinical Trial Approval of Sacituzumab Govi...

1/22/2021AZ and MSD's Granted Priority Review for New Indication of Lynparza (O...

1/22/2021Eli Lilly's NDA for Cyramza (Ramucirumab) Accepted in China

1/22/2021GSK Granted Priority Review for NDA of Two-in-One HIV Drug Juluca in C...

1/22/2021Recent Executive Moves

1/21/2021Jemincare Initiates Phase I Trial of Anti-SARS-Cov-2 Neutralizing Anti...

Page:234/807 Total number of articles:24185: [First][<<] [232] [233] [234] [235] [236] [>>] [End]